Literature DB >> 24825983

3d QSAR studies on a series of quinazoline derrivatives as tyrosine kinase (egfr) inhibitor: the k-nearest neighbor molecular field analysis approach.

Malleshappa N Noolvi1, Harun M Patel1.   

Abstract

Epidermal growth factor receptor (EGFR) protein tyrosine kinases (PTKs) are known for its role in cancer. Quinazoline have been reported to be the molecules of interest, with potent anticancer activity and they act by binding to ATP site of protein kinases. ATP binding site of protein kinases provides an extensive opportunity to design newer analogs. With this background, we report an attempt to discern the structural and physicochemical requirements for inhibition of EGFR tyrosine kinase. The k-Nearest Neighbor Molecular Field Analysis (kNN-MFA), a three dimensional quantitative structure activity relationship (3D- QSAR) method has been used in the present case to study the correlation between the molecular properties and the tyrosine kinase (EGFR) inhibitory activities on a series of quinazoline derivatives. kNNMFA calculations for both electrostatic and steric field were carried out. The master grid maps derived from the best model has been used to display the contribution of electrostatic potential and steric field. The statistical results showed significant correlation coefficient r(2) (q(2)) of 0.846, r(2) for external test set (pred_r2) 0.8029, coefficient of correlation of predicted data set (pred_r(2)se) of 0.6658, degree of freedom 89 and k nearest neighbor of 2. Therefore, this study not only casts light on binding mechanism between EGFR and its inhibitors, but also provides hints for the design of new EGFR inhibitors with observable structural diversity.

Entities:  

Keywords:  Quinazoline; Tyrosine kinase (E GFR); k-Nearest Neighbor Molecular Field Analysis (kNN-MFA)

Year:  2010        PMID: 24825983      PMCID: PMC3979194     

Source DB:  PubMed          Journal:  J Basic Clin Pharm        ISSN: 0976-0113


  2 in total

1.  Identification of novel small molecules that inhibit STAT3-dependent transcription and function.

Authors:  Iryna Kolosenko; Yasmin Yu; Sander Busker; Matheus Dyczynski; Jianping Liu; Martin Haraldsson; Caroline Palm Apergi; Thomas Helleday; Katja Pokrovskaja Tamm; Brent D G Page; Dan Grander
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

2.  3D-QSAR studies on fluroquinolones derivatives as inhibitors for tuberculosis.

Authors:  Atanu Bhattacharjee; Baphilinia Jones Mylliemngap; Devadasan Velmurugan
Journal:  Bioinformation       Date:  2012-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.